Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.83
-0.51 (-4.13%)
At close: Mar 20, 2026, 4:00 PM EDT
11.70
-0.13 (-1.10%)
After-hours: Mar 20, 2026, 7:26 PM EDT

Amneal Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
310.87118.4299.1135.23256.74
Cash & Short-Term Investments
310.87118.4299.1135.23256.74
Cash Growth
162.52%19.49%181.34%-86.28%-26.04%
Accounts Receivable
895.14775.73613.73741.79662.58
Other Receivables
0.470.480.960.51.18
Total Trade Receivables
895.61776.22614.69742.29663.76
Inventory
606.3612.45581.38530.74489.39
Other Current Assets
98.480.7282.69103.57110.22
Total Current Assets
1,9111,5881,3781,4121,520
Net Property, Plant & Equipment
550.33523.69550.14589.36639
Other Intangible Assets
563.5732.38890.421,0961,167
Goodwill
595.47597.44598.63598.85593.02
Other Long-Term Assets
57.8160.1355.52103.2220.61
Total Assets
3,6783,5013,4733,7993,940
Accounts Payable
761.32735.45534.66538.2525.35
Short-Term Debt
-10017960-
Current Portion of Long-Term Debt
6.76224.2134.1329.9630.61
Current Portion of Leases
14.8216.0414.514.6815.42
Other Current Liabilities
98.7454.0784.31109.96105.86
Total Current Liabilities
881.631,130846.6752.8677.24
Long-Term Debt
2,5652,1622,4272,6322,718
Long-Term Leases
102.3691.0995.45108.81111.93
Other Long-Term Liabilities
123.21163.3341.7797.1248.52
Total Long-Term Liabilities
2,7912,4162,5652,8382,879
Total Liabilities
3,6723,5463,4113,5903,556
Common Stock
3.153.13.073.043.01
Additional Paid-in Capital
571.79560.21539.24691.63658.35
Accumulated Other Comprehensive Income
-110.73-65.51-32.359.94-24.83
Retained Earnings
-535.01-607.06-490.18-406.18-276.2
Total Common Shareholders' Equity
-142.12-218.7839.79482.4727.31
Minority Interest
76.7664.7341.52-89.4923.54
Shareholders' Equity
-65.37-154.0581.32392.91750.85
Total Liabilities & Equity
3,6783,5013,4733,7993,940
Total Debt
2,6892,5932,7512,8452,876
Net Cash (Debt)
-2,378-2,475-2,651-2,810-2,619
Net Cash Per Share
-7.32-8.01-15.05--
Book Value
-142.12-218.7839.79482.4727.31
Book Value Per Share
-0.44-0.710.23--
Tangible Book Value
-1,301-1,549-1,449-1,213-1,033
Tangible Book Value Per Share
-4.01-5.01-8.23--
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q